Pharmaceutical Companies
Vaxart
๐บ๐ธUnited States
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines...
XBiotech
๐บ๐ธUnited States
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The...
Inovio Pharmaceuticals
๐บ๐ธUnited States
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100,...
Mersana Therapeutics
๐บ๐ธUnited States
Innate Pharma, Inc.
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $191M
- Website
- -
Race Oncology
๐ง๐ชBelgium
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $190.9M
- Website
- -
SKYE BIOSCIENCE INC
๐บ๐ธUnited States
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders,...
Context Therapeutics
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 5
- Market Cap
- $187.4M
- Website
- -
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform...
MediWound
๐ฎ๐ฑIsrael
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product...
Greenwich LifeSciences
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 7
- Market Cap
- $183.8M
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered...
